The Food and Drug Administration has granted Fast Track designation to LTG-001 for the treatment of acute pain.

The final two patients were discharged from acute care Monday and are now in inpatient rehab, the Arizona Burn Center said.

Sarepta stock may recover sharply as additional information and data reveal that the adverse event reported by the company is ...

Review reveals nonsteroidal anti-inflammatory drugs are effective for acute pain and 5 treatments are effective for chronic pain.

NSAIDs also help with acute pain, but they should be used sparingly. Nonsteroidal anti-inflammatory drugs (NSAIDs) like ...

Each year, millions of people in America are prescribed a medicine for acute pain.Now, for the first time in over 20 years, ...

Only around one in every 10 treatments were found to be effective in relieving lower back pain, according to a new study ...

With over 10 million people affected worldwide, Parkinson's disease is the fastest-growing neurological disorder. More than ...

The Company is currently analyzing the case and will update the prescribing information for Elevidys to note this development.

The American College of Physicians strongly recommends adding a triptan to an NSAID to treat adults with moderate to severe ...

The patient, whom Sarepta described as a young man and later told news outlets was 16 years old, suffered acute liver failure ...

ACP released new clinical guidance on outpatient treatment of acute episodic migraine with combination therapy in patients ...